1. Khoo SK and Mackay EV. Immunologic reactivity of female patients with genital cancer: status in preinvasive, locally invasive and disseminated disease, Am. J. Obstet. Gynecol., 119 (1974) 1018–1025.
2. Markman M and Howell SB. Intraperitoneal chemotherapy for ovarian cancer, In Alberts DS, Surwit EA (eds), Ovarian Cancer. Martinus Nijhoff, Boston, 1985, pp. 179–212.
3. Clark JW. Biological response modifiers. Cancer Chemother. Biol. Response Modif. 17 (1997) 287–315.
4. Benjamini E, Rennick DM, and Sell S. Tumor immunology, In Stites DP, et al. (eds), Basic and Clinical Immunology, Lange, Los Altos, CA, 1984, 223.
5. Boyer P, Berek JS, and Zigelboim J. Lymphocyte activation by recombinant interleukin-2 in ovarian cancer patients, Obstet. Gynecol., 73 (1989) 793–797.